OLMA compared with SLDB: revenue, margins and what each company keeps, and the suppliers and customers both name

OLMAOlema Pharmaceuticals, Inc.

Mkt capRevenueRevenue

SLDBSolid Biosciences Inc.

Mkt capRevenueRevenue

Compare

OLMAOlema Pharmaceuticals, Inc.

SLDBSolid Biosciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OLMA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±30.4%▼−12.65%×0.42

May 12 '26±32.7%▼−5.99%×0.18

Q1 FY26±31.6%▲+12.85%×0.41

Jan 13 '26±6.4%▼−3.13%×0.48

SLDB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q1 FY26±75.6%▲+18.81%×0.25

Q3 FY25±38.3%▼−15.29%×0.40

= impliedOLMA realized, solidSLDB realized, hatchedOne scale, both sides: full bar = 76%× = |realized| ÷ impliedspan: OLMA 210d · SLDB 791dSource: market data

Feb 18 '25

±29.3%

▲+31.51%

×1.08

Jan 8 '24±15.0%▲+7.59%×0.51

OLMAOlema Pharmaceuticals, Inc.

7.05▲+0.71%· post 7.05

Mkt cap$618.6M

SLDBSolid Biosciences Inc.

6.17▼−0.56%· post 5.99

ClosedNov 2 '26

Mkt cap$664.8M

Compare

ClosedNov 2 '26

OLMAOlema Pharmaceuticals, Inc.

SLDBSolid Biosciences Inc.

7.05▲+0.71%post 7.05

Price

6.17▼−0.56%post 5.99

$618.6M

Mkt cap

$664.8M

OLMA7.05▲+0.71%vsSLDB6.17▼−0.56%ClosedNov 2 '26